Health & Biotech
Cellmid (ASX: CDY) has changed its name to Anagenics - AN1 (ASX: AN1).
Below are the previous articles from Cellmid (ASX: CDY):
RELATED STOCKHEAD STORIES
News
Kick Back: The 10 biggest stories you might have missed on Stockhead this week
News
Weekly ASX small cap wrap: Who’s bagging the small cap gains this week?
News
March Winners Column: Which stocks do investors choose when the world is in lockdown?
News
Going Viral: All the COVID news you want to read this week
News
Lunchtime ASX small cap wrap: Who’s getting cabin fever today?
Health & Biotech
Cellmid shares jump after securing deal on Chinese COVID-19 testing kits
News
10 at 10: These ASX stocks are on a victory lap this morning
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Health: Resonance gets investor thumbs up after signing another US deal
Health & Biotech
Asia is where health investors are making money this year
Health & Biotech
9 of the most interesting biotech bosses in the game today: part 1
News
Rise and shine: What you need to know before the ASX opens
News
Rise & Shine: What you need to know before the ASX opens
Health & Biotech
Health: PainChek expands into Singapore with landmark deal
Health & Biotech
Health: Cann Group gets the next tick of approval for its medicinal cannabis operations
Health & Biotech
Health: Cellmid says Japan is going bonkers for its line of hair-loss products
News